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Plasmodium falciparum malaria remains one of the most serious health problems globally.
Immunization with attenuated parasites elicits multiple cellular effector mechanisms capable of
eliminating Plasmodium from the liver. However, malaria liver stage immunity is complex. The
anatomic site of priming of naive Plasmodium-specific CD8 T cells, be it in the lymph nodes
draining the site of Plasmodium antigen deposition by the mosquito or in the liver, may in fact
determine the specificity of the effector CD8 T cells. The participation of particular antigen-
presenting cells (Corradin and Levitskaya, 2014) and tissue signatures that influence the activation
of intrahepatic CD8 T cells against malaria sporozoites (Morrot and Rodrigues, 2014) are still
incompletely understood. Similarly, how effector CD8 T cells detect the few infected hepatocytes
in the large liver and the mechanisms they use to kill the intracellular parasites are unknown.
The unique immunological properties of the liver could explain why effector CD8 T cells are so
inefficient in finding and eliminating the hepatic stages of Plasmodium (Bertolino and Bowen,
2015). Effector CD8 T cells require help from CD4 T cells, and antigen-presenting cells are thought
to stimulate CD4 T cell licensing and enhance their capacity to optimally activate CD8 T cells
(Crispe, 2014). Helper CD4 T cells also aid in the development of B cell-mediated immunity
(Dups et al., 2014). High levels of interstitial antibodies can immobilize sporozoites in the skin
and circulating antibodies can prevent the parasites from infecting the liver (Vanderberg, 2015). A
better understanding of fine specificity and quantities of antibodies required for protection and the
antigens recognized by neutralizing antibodies will facilitate the design of refined malaria vaccines
that induce robust, long-lived, protective B cell responses (Dups et al., 2014).
Animal models have traditionally played an important role in the discovery of the basic
parameters of CD8 T cell-mediated immunity, as ethical and practical limitations preclude
study of the cellular and molecular mechanisms by which malaria vaccines induce protection in
humans. Highlighting the complexity of Plasmodium liver stage immunity, comparison of murine
malaria models led to the identification of protective memory CD8 T cell responses that differed
quantitatively and qualitatively, depending on the Plasmodium species (Van Braeckel-Budimir and
Harty, 2014).
The mechanisms effector CD8 T cells use to recognize and eliminate Plasmodium from the
liver are also unknown. Adoptive transfer of circumsporozoite protein-specific CD8 T cells into
transgenic mice that express matching MHC class I molecules either exclusively on hepatocytes or
on dendritic cells suggests that recognition of hepatocytes is sufficient to confer protection (Huang
et al., 2015). However, the formation of immunological synapses between T cells and hepatocytes
has not been observed in the intact liver suggesting that classical granule-mediated cytotoxicity
is dispensable for parasite killing. In fact, mounting evidence suggests that effector CD8 T cells
elicited by attenuated sporozoite vaccines recognize a subpopulation of hepatic dendritic cells
and use cytokines to eliminate the parasites at a distance, without direct contact with infected
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hepatocytes (Frevert and Krzych, 2015). This model is supported
by the lymphogenic features of the liver (Frevert and Krzych,
2015). The contribution of Kupffer cells and other liver-resident
and recruited antigen-presenting cells to the effector phase
against Plasmodium likely varies with the immune status of the
host (Bertolino and Bowen, 2015; Frevert and Krzych, 2015).
The observation that both antigen-specific and antigen-
unrelated CD8 T cells cluster around infected hepatocytes
led to the proposal that antigen-specific effector CD8 T cells
recruit other T cells to the site of infection and that the
resulting inflammatory microenvironment augments parasite
killing by antigen-specific and antigen-unrelated bystander
cells (Bayarsaikhan et al., 2015). The significance of antigen-
dependent focal inflammation and its consequences for the
elimination of the intracellular parasites is discussed (Fernandes
et al., 2014).
Unlike P. falciparum and rodent species, P. vivax forms
dormant liver stages that may relapse weeks, months, or years
after the primary infection, leading to new bouts of illness. Non-
human primate model systems have been developed to study the
immunobiology of the relapse phenomenon and to screen for
biomarkers for P. vivax and a related simian parasite (Joyner
et al., 2015).
The liver is also a central player in the defense against
Plasmodium blood stages. Activation of Toll-like receptors
(TLRs), acute phase proteins, phagocytic activity, and cytokine-
mediated pro- and anti-inflammatory responses are all part of the
liver-inherent immune system (Wunderlich et al., 2014).
Efforts to develop a successful malaria vaccine have been the
focus of substantial research activities for decades. Immunization
with live-attenuated sporozoites can elicit sterile immunity.
Whether attenuation is achieved by irradiation or genetic
modification, CD8 T cells play an essential role in the
resulting sterilizing protection in several experimental models.
Inoculation of infectious sporozoites under chemoprophylaxis
also confers long-lasting sterile protection against homologous
parasite strains in humans, although the exact mechanism is
unclear. Chloroquine, the first drug used for chemoprophylaxis,
neither eliminates Plasmodium liver stages nor delays parasite
development (Sahu et al., 2015). Anti-malarial compounds such
as quinine, quinones, and resveratrol, which may be present in
the diet of individuals living in some endemic areas, are thought
to contribute to protection against blood stage infection (Dalai
et al., 2015).
Unlike whole organism vaccines, most subunit vaccine
candidates fail to induce substantial and lasting protection.
Novel approaches are therefore under investigation to identify
antigens responsible for protection against the different parasite
stages (Chia et al., 2014). These include the mining of
genomic, proteomic and transcriptomic datasets to rationally
identify immunological signatures associated with more potent
immunity than occurs after natural exposure (Proietti and
Doolan, 2014). Another focus is on novel non-inflammatory
nanoparticle-based adjuvants, which induce high CD8 T cell
responses without expandingmyeloid-derived suppressor cells or
inflammation-reactive Tregs at the site of priming (Wilson et al.,
2015).
We hope that this Frontiers eBook offers insight into the many
efforts aiming at breaking the life cycle of Plasmodium in the
liver. Amore thorough understanding of themechanisms leading
to sterile protection is a prerequisite for developing a malaria
vaccine that protects the 40% of the world’s population at risk of
infection. We thank all contributing authors for bringing a broad
range of expertise to this Frontiers Topic.
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